Trial Review

ANZCTR is currently experiencing a technical issue. Thank you for your patience while we work on it and apologies for any inconvenience caused.


Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements.
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT05273580




Registration number
NCT05273580
Ethics application status
Date submitted
1/03/2022
Date registered
10/03/2022
Date last updated
15/02/2023

Titles & IDs
Public title
Wearable and Patient-reported Outcome-based Continuous Assessment and Support Alerts in Palliative Care
Scientific title
Wearable and Patient-reported Outcome-based Continuous Assessment and Support Alerts in Advanced Cancer Patients and Their Carers
Secondary ID [1] 0 0
wePRO-CASA
Universal Trial Number (UTN)
Trial acronym
wePRO-CASA
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Palliative Care 0 0
Wearable Electronic Devices 0 0
Patient Reported Outcome Measures 0 0
Cancer 0 0
Caregiver 0 0
Digital Health 0 0
Condition category
Condition code

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Treatment: Devices - Garmin VivoSmart 4
Treatment: Devices - mema - ilumivu

Patients - Eligible patients will be identified by the Nurse Practitioner Cancer \& Palliative Care.

Carers - The respective carers who are identified by the Nurse Practitioner Cancer \& Palliative Care as eligible participants.


Treatment: Devices: Garmin VivoSmart 4
Wearable sensor to record; sleep, stress, heart rate etc.

Treatment: Devices: mema - ilumivu
mEMA is the a self-service platform running on both iOS and Android that is specifically designed for the administration of mobile Ecological Momentary Assessment or Experience Sampling research studies.
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Wearable compliance
Timepoint [1] 0 0
5 weeks
Secondary outcome [1] 0 0
Quantitative and qualitative exploration of EMA/EMI acceptability
Timepoint [1] 0 0
2 hours
Secondary outcome [2] 0 0
Correlative analysis of WS signals and ePRO's
Timepoint [2] 0 0
5 weeks

Eligibility
Key inclusion criteria
* Palliative care patient attending at Northern Sydney Cancer Centre, RNSH
* Patient and carer dyad
* Both patient and carer consent
* Patient Karnofsky Performance Scale = 50
* Patient and carer have compatible smart phone
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
• Unwilling or unable to give informed consent

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
15/04/2021
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
12/11/2021
Sample size
Target
Accrual to date
Final
30
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Royal North Shore Hospital - St Leonards
Recruitment postcode(s) [1] 0 0
2067 - St Leonards

Funding & Sponsors
Primary sponsor type
Other
Name
Royal North Shore Hospital
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Thilo Schuler
Address 0 0
Royal North Shore Hospital
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT05273580